|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02633 JACOBSON PHARMA
Nominal 
1.050 +0.060 (+6.061%) | 2024/09 - Interim HKD(K$) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | -- | 484,363 | 630,090 | 406,942 | 409,258 |
| Net Cash from / (used in) Investing Activities | -- | 43,342 | (134,983) | (49,938) | (373,313) |
| Net Cash from / (used in) Financing Activities | -- | (1,053,255) | (36,598) | (357,888) | 21,355 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (525,550) | 458,509 | (884) | 57,300 |
| Cash & Cash Equivalents at beginning of period | -- | 936,418 | 478,653 | 480,350 | 421,441 |
| Effect of Foreign Exchange Rate Changes | -- | 1,069 | (744) | (813) | 1,609 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 411,937 | 936,418 | 478,653 | 480,350 |
| Remarks: | Real time quote last updated: 27/12/2024 16:11 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 140,290,000 |
| %Change | -8.926% |
| EPS / (LPS) | HKD 0.071 |
| NBV Per Share ($) | HKD 1.216 |